Assay Kits for Lumipulse instrument
ID: 75N95024Q00005-SSType: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/e99536a50841401ebeb3745ec6f4132d/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from qualified sources regarding the availability of assay kits for the Lumipulse G1200 instrument, which is essential for conducting assays related to Alzheimer's disease biomarkers. The procurement aims to acquire state-of-the-art assay kits for quantifying serum/plasma levels of abeta42, abeta40, and pTau 217, which will be utilized in ongoing research involving stored specimens from the Baltimore Longitudinal Study of Aging (BLSA). Interested vendors are encouraged to submit capability statements detailing their ability to meet the project requirements, including manufacturing details and company qualifications, by October 28, 2024, at 5 PM Eastern Time, to Iris Merscher at iris.merscher@nih.gov. This notice serves as a Sources Sought announcement and does not constitute a solicitation for proposals or quotes.

    Point(s) of Contact
    Iris Merscher
    (301) 827-2547
    iris.merscher@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Assay Kits for Lumipulse instrument
    Currently viewing
    Sources Sought
    Similar Opportunities
    cDNA-PCR Sequencing Kits for long-read sequencing.
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from qualified sources regarding the availability of cDNA-PCR sequencing kits for long-read sequencing, as part of a Sources Sought notice. The primary objective is to procure PromethION flow cells and sequencing kits that are compatible with the Oxford Nanopore PromethION device, which is essential for high-throughput sequencing in research on Alzheimer’s disease and related dementias. These consumables will facilitate the analysis of DNA and RNA samples, aiding in the identification of potential therapeutic targets and biomarkers for Alzheimer's disease. Interested companies must submit their capability statements by October 28, 2024, at 5 PM Eastern Time, to Iris Merscher at iris.merscher@nih.gov, ensuring that all submissions adhere to the specified guidelines and page limits.
    Reagent Dispenser
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking information on domestically manufactured reagent dispensers through a Sources Sought notice. The procurement aims to identify U.S.-made products that meet stringent specifications, including features such as custom plate addition, high precision peristaltic pumping, and a dispensing volume capacity ranging from 0.5 to 2500μl, among others. This initiative underscores the importance of domestic manufacturing in scientific and medical instrumentation, aligning with the Buy American Act and Executive Order 14005. Interested vendors must submit their capability statements by October 25, 2024, to Kelly Lowe at kelly.lowe@nih.gov, ensuring compliance with the outlined requirements and confidentiality stipulations.
    Reagent Generation for Bioanalytical Method Development on Biologics
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources for a potential contract focused on reagent generation for bioanalytical method development related to biologics. The primary objective is to obtain information on the availability and capability of companies to generate and deliver reagents, including anti-drug antibodies, that support the quantification of novel biologic drugs in various biological matrices. This initiative is crucial for advancing drug development processes and improving success rates in preclinical stages, with the Therapeutic Development Branch (TDB) at NIH playing a pivotal role in moving therapeutic candidates through the drug development pipeline. Interested parties must submit their capability statements by November 8, 2024, to Nick Niefeld at nick.niefeld@nih.gov, referencing sources sought notice number 75N95025R00007.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Therakos Cellex Photopheresis System Procedural Kits for the Department of Transfusion Medicine
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a firm-fixed price contract for the procurement of five cases of Therakos Cellex USA Kits, essential for emergent Extracorporeal Photopheresis (ECP) procedures at the NIH Clinical Center in Bethesda, Maryland. These procedural kits are critical for patient care, particularly for those undergoing post-stem-cell transplant treatments, as they are the only compatible kits for the THERAKOS® CELLEX® Photopheresis System Instrument. Interested parties capable of providing similar products are encouraged to submit a capability statement by October 20, 2024, at noon EST, to Tasha Lowe at lowet2@mail.nih.gov, as the procurement will follow simplified acquisition procedures exempt from competitive requirements.
    Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is planning to award a Firm-Fixed price purchase order for various reagents and consumables necessary for clinical patient care testing at the NIH Clinical Center. The procurement is intended to secure proprietary products from Life Technologies Corporation, which are essential for diagnosing and monitoring hematological disorders, ensuring compliance with regulatory standards, and maintaining the integrity of laboratory operations. Interested vendors capable of providing equivalent products are invited to submit capability statements by the specified deadline, with inquiries directed to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov. The acquisition will adhere to the simplified acquisition threshold and is being conducted under FAR Subpart 13.106-1(b)(i) for sole source procurement.
    BD Biosciences BD FACSLyric™ 3L10C Lease, Consumables and Service
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking qualified contractors to provide leasing, consumables, and maintenance services for the BD FACSLyric™ 3L10C system, as part of a sources sought announcement. The procurement aims to ensure the continued operation of critical laboratory equipment used for immunology flow cytometry, which is essential for delivering over one million test results annually for patient care and research. This opportunity emphasizes the need for proprietary reagents and robust support from the manufacturer, highlighting the importance of consistent and reliable testing in a clinical research environment. Interested parties must submit their responses by 12:00 PM Eastern Standard Time on October 23, 2024, to the primary contact, Kimala Winfield, at kimala.winfield@nih.gov.
    SERVICE AGREEMENT FOR FACSYMPHONY A5 SPECTRAL CELL ANALYZER AND HIGH THROUGHPUT SAMPLER
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a qualified contractor to provide a service agreement for the BD FACSymphony A5 Spectral Cell Analyzer and High Throughput Sampler. The procurement includes comprehensive coverage for parts, labor, and preventative maintenance, ensuring the operational efficiency of critical laboratory equipment used in research and diagnostics. The contract will be awarded based on technical capability and price, with a performance period from December 13, 2024, to December 12, 2025. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by October 21, 2024, at 12:00 am EST, and can contact Maliaka Pinkney at maliaka.pinkney@nih.gov for further inquiries.
    The Navy Medical Readiness Logistics Command Detachment Fort Detrick has a requirement for the Drug Demand Reduction Program, for the initial (screen) immunoassay for the detection of 6-Acetylmorphine Immunoassay Reagent Kits in urine > 10 ng/mL.
    Active
    Dept Of Defense
    The Department of Defense, specifically the Navy Medical Readiness Logistics Command Detachment Fort Detrick, is seeking proposals for the procurement of FDA-approved Immunoassay Reagent Kits designed for the detection of 6-acetylmorphine (6AM) in urine samples. The contract requires vendors to provide reagent kits compatible with Beckman Coulter AU5800 series analyzers, capable of conducting up to 500,000 tests per month over a five-year period, while adhering to stringent FDA and quality management documentation standards. This procurement is critical for the Drug Demand Reduction Program, ensuring accurate and reliable drug testing within the Department of Defense. Interested vendors must submit technical documentation by October 25, 2024, with final quotes due by November 22, 2024. For further inquiries, contact James Berghaier at 215-697-2022 or via email at james.berghaier@navy.mil.
    Notice of Intent for Meso Scale Discovery Sector S 600 Readers Service Contract
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source maintenance service contract with Meso Scale Diagnostics LLC for the servicing of MESO SECTOR S 600MM instruments located at its Gaithersburg, MD facility. The contract encompasses several service packages, including preventive maintenance inspections, repairs, and pre-contract inspections for specific instruments, with maintenance services set to commence between October 24, 2024, and April 17, 2025, and concluding on May 5, 2025. This procurement is critical for ensuring the operational reliability of laboratory equipment essential for research, and it mandates that vendors provide factory-trained technicians and OEM specification parts. Interested vendors must submit their capability statements and relevant documentation via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 10:00 AM on October 18, 2024, as this opportunity is not a request for proposals.